MAPK1 and Huntington disease: In 10 month‐old HdhQ111/+ mice, a late‐onset model of HD (Wheeler et al, 2000), RB5 also attenuated striatal neuronal degeneration (Fig 5C) while concomitantly enhancing ERK activity (Fig 5D).